Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    19577283 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Walnut Oral Immunotherapy for Tree Nut Allergy
Condition: Nut Hypersensitivities
Interventions: Drug: Walnut Protein Flour;   Drug: Oat flour
2 Completed Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy
Condition: Peanut Allergy
Intervention: Other: Peanut flour
3 Active, not recruiting Walnut Oral Immunotherapy for Tree Nut Allergy
Condition: Nut Hypersensitivities
Interventions: Drug: Walnut Protein Powder;   Drug: Oat Powder (placebo)

Indicates status has not been verified in more than two years